Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Forner

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
BMC Gastroenterology|February 3, 2025
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer riskNúria Granel, Gemma Iserte, Concepció Bartres, et al.
The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
JHEP Reports : Innovation in Hepatology|June 5, 2023
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinomaDavid J Pinato, Takahiro Kaneko, Antonio D'Alessio, et al.
The Lancet. Oncology|December 9, 2008
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisVincenzo Mazzaferro, Josep M Llovet, Rosalba Miceli, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Journal of Hepatology|February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA RegistryLaura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Radiology|November 16, 2021
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-AnalysisChristian B van der Pol, Matthew D F McInnes, Jean-Paul Salameh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2022
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort StudySergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
BMC Gastroenterology|February 3, 2025
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer riskNúria Granel, Gemma Iserte, Concepció Bartres, et al.
The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
JHEP Reports : Innovation in Hepatology|June 5, 2023
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinomaDavid J Pinato, Takahiro Kaneko, Antonio D'Alessio, et al.
The Lancet. Oncology|December 9, 2008
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisVincenzo Mazzaferro, Josep M Llovet, Rosalba Miceli, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Journal of Hepatology|February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA RegistryLaura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Radiology|November 16, 2021
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-AnalysisChristian B van der Pol, Matthew D F McInnes, Jean-Paul Salameh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2022
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort StudySergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Pageof 11